From the laboratory to trials to routine use of phage in treating human infections

14.00 BST

Prof. Martha Clokie Profile Image

Professor of Microbiology at the University of Leicester with experience in developing bacteriophage products

@MarthaClokie

Dr. Melissa Haines Profile Image

Clinical lecturer specialising in developing phages for clinical use

@MelissaEKHaines

Can phages help address the challenges of AMR?

14.15 BST

Dr. Marie Noelle Vieu, MD Profile Image

Dr. Marie Noelle Vieu, MD

Public health consultant with experience in infectious disease management and health care needs analysis

Challenges of AMR; a clinical perspective and the acceptability of new alternatives

14.35 BST

David Jenkins Profile Image

David Jenkins

Dr David Jenkins is a renowned medical microbiologist and infection prevention specialist and President of BSAC. David has served as lead infection prevention clinician at University Hospital Leicester for over 20 years.

Break

15.10 BST

Phage therapy for compassionate use - lessons learned for clinical trials

15.25 BST

Karen Adler Profile Image

Microbiologist with a wealth of experience in researching phages for multidrug-resistant pathogens, currently leading the laboratory research component of the project

@kadler42

Immune response to phage and phage pharmacokinetics

15.40 BST

Krystyna Dabrowska Profile Image

Krystyna Dabrowska

Professor of Molecular Microbiology at the Hirszfeld Institute of Immunology and Experimental Therapy in Wrocław, Poland, with experience in immune responses to phage, phage pharmacokinetics, and antibacterial potential of phages in vivo.

Phage clinical trials: not a novelty. What can the UK learn from other countries?

16.00 BST

Shawna McCallin Profile Image

Shawna McCallin

Dr. Shawna McCallin is a clinical trial coordinator and senior phage researcher at the Balgrist University Hospital at the University of Zürich, Switzerland.

Phage regulations and treatments; Belgium perspective

17.00 BST

Jean-Paul Pirnay Profile Image

Jean-Paul Pirnay

Dr. Jean-Paul Pirnay is head of the Laboratory for Molecular and Cellular Technology (LabMCT) and Research Manager of the Queen Astrid Military Hospital, where he contributed to the development of the human cell and tissue banks and to the re-introduction of phage therapy.

Phage regulation panel discussion

17.20 BST

Prof. Martha Clokie Profile Image

Professor of Microbiology at the University of Leicester with experience in developing bacteriophage products

@MarthaClokie

Should phage therapy be part of AMR strategy? What are the next steps?

17.40 BST

Prof. Martha Clokie Profile Image

Professor of Microbiology at the University of Leicester with experience in developing bacteriophage products

@MarthaClokie

Dr. Melissa Haines Profile Image

Clinical lecturer specialising in developing phages for clinical use

@MelissaEKHaines

Questions & reflections from the audience

14.55 BST

Prof. Martha Clokie Profile Image

Professor of Microbiology at the University of Leicester with experience in developing bacteriophage products

@MarthaClokie

Break

16.45 BST

Clinical trials of phage therapy in the UK: Making it a reality

16.30 BST

Panel discussion led by Prof. Martha Clokie

Prof. Martha Clokie Profile Image

Professor of Microbiology at the University of Leicester with experience in developing bacteriophage products

@MarthaClokie